PLA2G4A and early-onset autosomal dominant Alzheimer disease: Later studies reported the presence of cPLA2 immunoreactivity in rodent models of focal and global cerebral ischemia and amyotrophic lateral sclerosis, as well as brain tissue from Alzheimer’s disease [21, 46, 47].